Varenicline is an organic heterotetracyclic compound that functions as a partial agonist for nicotinic cholinergic receptors and is used (in the form of its tartate salt) as an aid to giving up smoking. Among its listed roles, it functions as a nicotinic acetylcholine receptor agonist and a serotonergic agonist. It is a secondary amino compound, an organic heterotetracyclic compound and a bridged compound. It is grouped under the following drug class(es): Neurotransmitter agents. Its therapeutic use is listed as alcohol dependence agents and smoking cessation agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Champix, Vareniclina and Vareniclinum. Its PubChem CID is 5310966.
Varenicline
| CAS No | 249296-44-4 |
|---|---|
| Molecular Formula | C13H13N3 |
| Molecular Weight | 211.26 g/mol |
| Synonyms | (1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Varenicline is an organic heterotetracyclic compound that functions as a partial agonist for nicotinic cholinergic receptors and is used (in the form of its tartate salt) as an aid to giving up smoking.
The listed CAS number is 249296-44-4.
The listed molecular formula is C13H13N3.
The listed molecular weight is 211.26 g/mol.
(1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene.
The source lists Champix, Vareniclina and Vareniclinum.